Investigating how oral iron doses affect serum ferritin levels in iron-deficient women
Official title: Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
Run by Swiss Federal Institute of Technology · NCT06851130 · Data updated 2026-11-12
This study tests how different doses of iron supplements affect iron levels in women aged 18 to 45 who have low iron but are not anemic.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Swiss Federal Institute of Technology Academic / other |
| Locations | 1 site (Zurich, Canton of Zurich) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 20, 2025 |
| Trial ID | NCT06851130 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 to 45 with low serum ferritin levels and no anemia.
✕Probably not a fit
Patients with chronic diseases, recent blood loss, or those who are pregnant or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the immediate effects of oral iron supplementation on serum ferritin levels in women with low iron stores but no anemia. Participants will receive either 80 mg or 160 mg of ferrous sulfate daily for two months to assess how these doses influence serum ferritin levels over time. The goal is to understand the acute changes in ferritin levels to improve monitoring of iron status during supplementation. The study focuses on women aged 18 to 45 with specific eligibility criteria to ensure accurate results.
Why it matters
Potential benefit: If successful, this study could lead to improved guidelines for monitoring iron supplementation in women with iron deficiency.
How similar studies have gone: While studies on iron supplementation exist, this specific investigation into acute serum ferritin response is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Low iron stores (SF levels \< 30 µg/L), * no anemia (Hb \> 120 g/L) * no inflammation (CRP \< 5 mg/L) * 18 to 45 years old. * Body weight \<70 kg * Normal body Mass Index (18.5-26.5 kg/m2) Exclusion Criteria: * Any chronic or acute disease * Consumption of mineral and vitamin supplements since screening and over the study period * Blood transfusion, blood donation or significant blood loss over the past 4 months, * Pregnant or breastfeeding, * Continuous/long-term use of medication during the whole studies (except for contraceptives) * Therapeutic iron infusion over the past 6 months, * Known hypersensitivity or allergy to iron supplements, * Intention to become pregnant over the course of the study
Where it's running
-
Laboratory of Nutrition and Metabolic Epigenetics
Zurich, Canton of Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: Nicole Stoffel, PhD
- Email: nicole.stoffel@hest.ethz.ch
- Phone: +41 44 632 83 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing Iron Levels in Pregnant Women During Early Pregnancy
This study is trying to find out the normal iron levels in healthy pregnant women during their first trimester to help spot iron deficiency early on.
-
Non-invasive zinc protoporphyrin screening for iron deficiency in pregnancy
This project tests a handheld device that measures zinc protoporphyrin through the lower lip to detect iron deficiency in pregnant and recently postpartum people.
-
How chitin and vitamin C affect iron absorption from edible insects
This test will see if adding chitin or vitamin C changes how well iron from edible insects is absorbed by women aged 18–45 with low iron stores.
-
Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia
This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.
-
Donor Breast Milk with Early Iron Supplementation in Very Preterm Infants
In very preterm babies who mainly receive donor breast milk, this study tests whether starting iron supplementation earlier (around when feeding reaches 80 ml/kg/day) can raise ferritin and hematocrit levels by days 14 and 28.
-
Preconception versus early-pregnancy iron screening and treatment
This trial tests whether screening and treating iron deficiency before conception is better than starting screening and iron treatment in early pregnancy for preventing iron deficiency anemia later in pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.